美农生物 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	490.0M	504.0M	483.0M	546.0M	421.0M
Revenue Growth %	-2.8%	4.3%	-11.5%	29.7%	--
Total Revenue	490.0M	504.0M	483.0M	546.0M	421.0M
Cost Of Revenue	349.0M	353.0M	343.0M	385.0M	268.0M
+Gross Profit	141.0M	151.0M	140.0M	161.0M	153.0M
Gross Margin %	28.8%	30.0%	29.0%	29.5%	36.3%
Total Operating Cost	440.0M	445.0M	426.0M	476.0M	351.0M
Selling Expenses	38.3M	37.6M	30.9M	35.8M	31.3M
Admin Expenses	31.6M	35.4M	31.2M	28.1M	23.7M
Rd Expenses	20.9M	22.0M	21.4M	22.5M	19.5M
Finance Expenses	-5.0M	-4.8M	-6.1M	2.5M	2.6M
+Operating Income	54.5M	66.7M	58.5M	79.2M	77.0M
Operating Margin %	11.1%	13.2%	12.1%	14.5%	18.3%
Non Operating Income	1.5M	3.9M	51,800	825,800	39,800
Non Operating Expenses	220,000	362,500	296,100	503,000	831,400
Investment Income	384,500	4.1M	-431,200	2.9M	2.4M
Fair Value Change Income	1.3M	-13,700	-285,500	392,700	896,000
Asset Disposal Income	353,700	35,000	-18,500	-1,200	-7,100
Asset Impairment Loss	1.4M	882,600	820,800	821,300	371,200
Other Income	2.6M	2.7M	2.0M	5.8M	4.4M
Income Before Tax	55.8M	70.2M	58.3M	79.5M	76.2M
Income Tax	6.2M	7.2M	5.8M	9.0M	9.5M
+Net Income	49.6M	63.0M	52.5M	70.6M	66.7M
Net Margin %	10.1%	12.5%	10.9%	12.9%	15.8%
Net Income Attributable	49.6M	63.0M	52.5M	70.6M	66.7M
Eps Basic	0.34	0.43	0.54	1.18	1.11
Eps Diluted	0.34	0.43	0.54	1.18	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	260.0M	360.0M	414.0M	121.0M	66.6M
Trading Financial Assets	40.5M	30.1M	5.0M	5.4M	1.6M
Accounts Receivable	104.0M	77.8M	113.0M	83.1M	85.1M
Notes Receivable	445,900	200,000	5.1M	--	--
Notes And Accounts Receivable	105.0M	78.0M	118.0M	83.1M	85.1M
Prepayments	9.7M	8.5M	9.5M	5.5M	8.4M
Inventory	67.5M	77.7M	63.8M	69.9M	60.1M
Total Current Assets	485.0M	561.0M	616.0M	300.0M	226.0M
Long Term Equity Investment	21.5M	23.0M	18.5M	20.3M	18.5M
Fixed Assets	--	205.0M	179.0M	36.8M	30.7M
Fixed Assets Total	202.0M	205.0M	179.0M	36.8M	30.7M
Construction In Progress	--	11.7M	32.0M	127.0M	42.2M
Construction In Progress Total	4.5M	11.7M	32.0M	127.0M	42.2M
Intangible Assets	65.9M	28.6M	28.8M	30.0M	14.2M
Long Term Deferred Expenses	3.1M	1.5M	1.9M	1.9M	1.4M
Total Non Current Assets	305.0M	278.0M	271.0M	230.0M	121.0M
Total Assets	790.0M	839.0M	887.0M	530.0M	347.0M
Short Term Borrowings	--	--	2.0M	34.8M	--
Accounts Payable	25.5M	17.1M	66.0M	57.5M	56.5M
Advance Receipts	--	--	--	--	--
Contract Liabilities	299,700	715,300	426,800	420,000	413,800
Total Current Liabilities	42.6M	37.9M	103.0M	138.0M	84.6M
Long Term Borrowings	--	--	--	66.6M	7.0M
Total Non Current Liabilities	2.8M	1.8M	1.7M	68.0M	8.4M
Total Liabilities	45.4M	39.7M	105.0M	206.0M	93.0M
Paid In Capital	145.0M	112.0M	80.0M	60.0M	60.0M
Capital Reserve	365.0M	398.0M	428.0M	42.6M	42.7M
Surplus Reserve	43.7M	39.2M	34.4M	30.2M	23.8M
Retained Earnings	234.0M	250.0M	240.0M	191.0M	127.0M
Equity Attributable	745.0M	799.0M	782.0M	324.0M	254.0M
Total Equity	745.0M	799.0M	782.0M	324.0M	254.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	492.0M	575.0M	482.0M	572.0M	395.0M
Tax Refunds Received	7.6M	3.9M	23.0M	5.3M	927,400
Total Operating Cash Inflow	507.0M	590.0M	510.0M	584.0M	402.0M
Cash Paid For Goods	309.0M	398.0M	340.0M	355.0M	248.0M
Cash Paid To Employees	79.6M	77.6M	68.2M	71.2M	48.0M
Taxes Paid	10.2M	12.9M	20.8M	20.2M	15.7M
Total Operating Cash Outflow	440.0M	530.0M	468.0M	494.0M	350.0M
Operating Cash Flow	67.2M	60.0M	42.1M	90.0M	51.2M
Total Investing Cash Inflow	372.0M	748.0M	634.0M	92.4M	323.0M
Total Investing Cash Outflow	436.0M	812.0M	682.0M	221.0M	314.0M
Investing Cash Flow	-64.3M	-64.0M	-48.1M	-128.0M	8.7M
Cash From Borrowings	1.0M	--	16.4M	123.0M	11.0M
Dividends And Interest Paid	60.9M	48.0M	3.1M	2.2M	30.4M
Debt Repayments	1.0M	2.0M	125.0M	24.0M	10.5M
Total Financing Cash Inflow	1.0M	2.7M	448.0M	123.0M	11.0M
Total Financing Cash Outflow	106.0M	51.0M	153.0M	32.3M	40.9M
Financing Cash Flow	-105.0M	-48.3M	295.0M	91.1M	-29.9M
Net Change In Cash	-99.6M	-51.3M	293.0M	51.2M	27.7M
Ending Cash Balance	260.0M	360.0M	411.0M	118.0M	66.6M
Capex	55.9M	38.5M	49.7M	126.0M	34.0M